Moberg Pharma AB (publ) MOB.ST Stock
36.48 SEK
{{ price }}
1.502507%
{{change_pct}}%
SECTOR
Healthcare
COUNTRY
Sweden
Exchange
Stockholm
Market Cap
1.06B SEK
LOW - HIGH [24H]
36.4
-
38.14 SEK
VOLUME [24H]
578K SEK
{{ volume }}
P/E Ratio
0
Earnings per share
-1.33 SEK
Moberg Pharma AB (publ) Price Chart
Moberg Pharma AB (publ) MOB.ST Financial and Trading Overview
| Moberg Pharma AB (publ) stock price | 36.48 SEK |
| Previous Close | 19.6 SEK |
| Open | 19.62 SEK |
| Bid | 19.32 SEK x 0 |
| Ask | 19.36 SEK x 0 |
| Day's Range | 19.2 - 19.62 SEK |
| 52 Week Range | 2.16 - 32.2 SEK |
| Volume | 9.79K SEK |
| Avg. Volume | 23.25K SEK |
| Market Cap | 210.94M SEK |
| Beta (5Y Monthly) | 0.861685 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.33 SEK |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | November 4, 2019 |
| 1y Target Est | 68 SEK |
MOB.ST Valuation Measures
| Enterprise Value | 113.13M SEK |
| Trailing P/E | N/A |
| Forward P/E | 6.42 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1019.01215 |
| Price/Book (mrq) | 0.3577266 |
| Enterprise Value/Revenue | 546.512 |
| Enterprise Value/EBITDA | -5.454 |
Trading Information
Moberg Pharma AB (publ) Stock Price History
| Beta (5Y Monthly) | 0.861685 |
| 52-Week Change | 4.14% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 32.2 SEK |
| 52 Week Low | 2.16 SEK |
| 50-Day Moving Average | 23.15 SEK |
| 200-Day Moving Average | 24.21 SEK |
MOB.ST Share Statistics
| Avg. Volume (3 month) | 23.25K SEK |
| Avg. Daily Volume (10-Days) | 22.59K SEK |
| Shares Outstanding | 9.83M |
| Float | 8.29M |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -10516.42% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -2.71% |
| Return on Equity (ttm) | -3.37% |
Income Statement
| Revenue (ttm) | 207K SEK |
| Revenue Per Share (ttm) | 0.02 SEK |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 207K SEK |
| EBITDA | -20741000 SEK |
| Net Income Avi to Common (ttm) | -16298000 SEK |
| Diluted EPS (ttm) | -1.61 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 84.54M SEK |
| Total Cash Per Share (mrq) | 8.6 SEK |
| Total Debt (mrq) | 4.86M SEK |
| Total Debt/Equity (mrq) | 0.92 SEK |
| Current Ratio (mrq) | 4.584 |
| Book Value Per Share (mrq) | 53.84 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -16718000 SEK |
| Levered Free Cash Flow (ttm) | -76692248 SEK |
Profile of Moberg Pharma AB (publ)
| Country | Sweden |
| State | N/A |
| City | Bromma |
| Address | GustavslundsvAegen 42 |
| ZIP | 167 51 |
| Phone | 46 8 52 23 07 00 |
| Website | https://www.mobergpharma.se |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 9 |
Moberg Pharma AB (publ), a pharmaceutical company, develops and commercializes medical products in Europe, the United States, and internationally. It develops MOB-015, which has completed Phase III clinical trial for the treatment of nail fungus. The company was formerly known as Moberg Derma AB (publ) and changed its name to Moberg Pharma AB (publ) in May 2013. Moberg Pharma AB (publ) was incorporated in 2006 and is headquartered in Bromma, Sweden.
Q&A For Moberg Pharma AB (publ) Stock
What is a current MOB.ST stock price?
Moberg Pharma AB (publ) MOB.ST stock price today per share is 36.48 SEK.
How to purchase Moberg Pharma AB (publ) stock?
You can buy MOB.ST shares on the Stockholm exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Moberg Pharma AB (publ)?
The stock symbol or ticker of Moberg Pharma AB (publ) is MOB.ST.
Which industry does the Moberg Pharma AB (publ) company belong to?
The Moberg Pharma AB (publ) industry is Drug Manufacturers-Specialty & Generic.
How many shares does Moberg Pharma AB (publ) have in circulation?
The max supply of Moberg Pharma AB (publ) shares is 29.09M.
What is Moberg Pharma AB (publ) Price to Earnings Ratio (PE Ratio)?
Moberg Pharma AB (publ) PE Ratio is now.
What was Moberg Pharma AB (publ) earnings per share over the trailing 12 months (TTM)?
Moberg Pharma AB (publ) EPS is -1.33 SEK over the trailing 12 months.
Which sector does the Moberg Pharma AB (publ) company belong to?
The Moberg Pharma AB (publ) sector is Healthcare.
Moberg Pharma AB (publ) MOB.ST included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| OMX_Stockholm_Small_Cap_PI OMXSSCPI | 1196.96 SEK 116.84 USD |
-0.26
|
— — | — — | — — | — - | — — |
| OMX Stockholm_PI OMXSPI | 947.32 SEK 92.47 USD |
-0.04
|
— — | — — | — — | — - | — — |
| OMX Stockholm All-Share Cap_GI OMXSCAPGI | 456.92 SEK 44.6 USD |
+0.02
|
— — | — — | — — | — - | — — |
| OMX_Nordic_Small_Cap_ISK_GI OMXNSCISKGI | 517.93 ISK 3.81 USD |
-0.71
|
— — | — — | — — | — - | — — |
| OMX_Nordic_Small_Cap_DKK_GI OMXNSCDKKGI | 349.16 DKK 51.19 USD |
-0.69
|
— — | — — | — — | — - | — — |
| OMX Stockholm Health Care PI SX4000PI | 2712.52 SEK 264.78 USD |
<0.01
|
— — | — — | — — | — - | — — |
| OMX Stockholm Health Care GI SX20GI | 4204.43 SEK 410.4 USD |
-0.07
|
— — | — — | — — | — - | — — |
| OMX Stockholm Pharmaceuticals a SX201030GI | 6954.45 SEK 678.84 USD |
+0.49
|
— — | — — | — — | — - | — — |
| OMX_Stockholm_Small_Cap_GI OMXSSCGI | 596.42 SEK 58.22 USD |
-0.19
|
— — | — — | — — | — - | — — |
| OMX Stockholm_GI OMXSGI | 466.5 SEK 45.54 USD |
+0.02
|
— — | — — | — — | — - | — — |
| OMX_Nordic_Small_Cap_SEK_GI OMXNSCSEKGI | 435.1 SEK 42.47 USD |
-0.21
|
— — | — — | — — | — - | — — |
| OMX_Nordic_Small_Cap_EUR_GI OMXNSCEURGI | 349.01 EUR 381.52 USD |
-0.71
|
— — | — — | — — | — - | — — |
| OMX Affarsvarldens Generalindex OMXAFGX | 923.83 SEK 90.18 USD |
-0.03
|
— — | — — | — — | — - | — — |
| OMX Stockholm Health Care PI SX20PI | 3276.93 SEK 319.87 USD |
-0.07
|
— — | — — | — — | — - | — — |
| OMX Stockholm Pharmaceuticals a SX201030PI | 5132.25 SEK 500.97 USD |
+0.49
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}